US Bancorp
BFRIW icon

US Bancorp’s Biofrontera BFRIW Stock Holding History

US Bancorp’s Portfolio BFRIW Stock Details BFRIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38 Hold
1,000
– – ﹤0.01% 4142
2025
Q4 		$90 Hold
1,000
– – ﹤0.01% 4002
2025
Q3 		$97 Hold
1,000
– – ﹤0.01% 3965
2025
Q2 		$105 Hold
1,000
– – ﹤0.01% 4109
2025
Q1 		$61 Hold
1,000
– – ﹤0.01% 4149
2024
Q4 		$61 Hold
1,000
– – ﹤0.01% 4118
2024
Q3 		$23 Hold
1,000
– – ﹤0.01% 4056
2024
Q2 		$35 Hold
1,000
– – ﹤0.01% 3946
2024
Q1 		$68 Hold
1,000
– – ﹤0.01% 3930
2023
Q4 		$10 Hold
1,000
– – ﹤0.01% 3951
2023
Q3 		$30 Hold
1,000
– – ﹤0.01% 3958
2023
Q2 		$110 Hold
1,000
– – ﹤0.01% 3939
2023
Q1 		$245 Buy
+1,000
New +$250 ﹤0.01% 4008

Other funds holding BFRIW

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

US Bancorp's BFRIW Position: Q1 2026 in Review

US Bancorp held its Biofrontera (BFRIW) position steady in Q1 2026 at 1,000 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

US Bancorp first reported a position in BFRIW in Q1 2023 and has held it in 13 quarters since. The position peaked at $245 in Q1 2023. 6 funds tracked by Wall St. Rank hold BFRIW as of Q1 2026.

  • US Bancorp held 1,000 shares of Biofrontera worth $38 as of Q1 2026.
  • US Bancorp left its Biofrontera share count unchanged in Q1 2026.
  • Biofrontera made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4142 holding.
  • US Bancorp first reported a position in Biofrontera in Q1 2023 and has held it in 13 quarters since.
  • US Bancorp's Biofrontera position peaked at $245 in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.